title: Should all cases of lung cancer be presented at Tumor Board Conferences?
abstract: Tumor Board Conferences (TBCs) have been associated with higher adherence of staging and treatment to guidelines. The influence of TBCs on the rate of curative treatments has been established. Patients with lung nodules and tumors of unknown histology should not be presented before surgery, but every patient with malignant histology should be declared to the TBC coordinator and registered at the time of histologic confirmation. This approach allows physicians to deal rapidly with simple cases on a systematic basis, to give more attention to the most complicated situations, and to offer every patient the benefit of a multidisciplinary approach.
authors.affiliation: Department of General Thoracic Surgery, Georges Pompidou European Hospital, Paris-Descartes University, 20 rue Leblanc, Paris 75015, France. marc.riquet@egp.aphp.fr
authors.forename: Marc
authors.initials: M
authors.lastname: Riquet
authors.forename: Pierre
authors.initials: P
authors.lastname: Mordant
authors.forename: Mehdi
authors.initials: M
authors.lastname: Henni
authors.forename: Delphine
authors.initials: D
authors.lastname: Wermert
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Fabre-Guillevin
authors.forename: Aurélie
authors.initials: A
authors.lastname: Cazes
authors.forename: Françoise
authors.initials: F
authors.lastname: Le Pimpec Barthes
mesh_terms: D003226:Congresses as Topic; D005602:France; D019983:Guideline Adherence; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D010348:Patient Care Team; D011379:Prognosis; D011787:Quality of Health Care / Q000592:standards*; D012042:Registries